文献速递炎症性肠病

中和性抗粒细胞巨噬细胞集落刺激因子自身抗体识别粒细胞巨噬细胞集落刺激因子上的翻译后糖基化并在诊断前数年预测复杂性克罗恩病

Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
PubMed 文献 · Gastroenterology · 2022-05-24

本研究基于美国国防医学监测系统的纵向血清样本,在220例诊断前克罗恩病患者与400名匹配健康对照中检测天然抗粒细胞巨噬细胞集落刺激因子自身抗体(aGMAbs)。研究发现中和性aGMAbs特异性识别粒细胞巨噬细胞集落刺激因子(GM-CSF)的翻译后糖基化,可在诊断前数年检出,并与就诊时复杂性克罗恩病相关;aGMAbs影响髓系稳态并促进1型固有淋巴细胞,免疫稳态紊乱在诊断前即出现于血清及非炎症黏膜。

要点

  • 中和性aGMAbs识别GM-CSF翻译后糖基化,可在克罗恩病诊断前数年检出。
  • aGMAbs与就诊时复杂性克罗恩病相关,并影响髓系细胞与1型固有淋巴细胞平衡。
  • 克罗恩病患者GM-CSF糖基化改变,免疫稳态紊乱可见于非炎症黏膜。

核心结论

  • 抗GMAbs在克罗恩病诊断前很久即可预测复杂性克罗恩病的诊断,识别独特糖基化表位,并损害与肠道免疫稳态改变相关的髓系细胞和固有淋巴细胞平衡。

研究设计与样本

  • 研究使用酶联免疫吸附试验表征美国国防医学监测系统中诊断克罗恩病前存档的纵向血清样本(n=220)及400名匹配健康对照中的天然aGMAbs。
  • 采用生化、细胞和转录分析揭示克罗恩病黏膜诊断后免疫平衡受损的机制。

主要发现

  • 中和性aGMAbs对GM-CSF上的翻译后糖基化具有特异性,可在诊断前数年检出,并与就诊时复杂性克罗恩病相关。
  • 克罗恩病患者GM-CSF糖基化发生改变,aGMAb影响髓系稳态并促进1型固有淋巴细胞。
  • 在表现为aGMAb的克罗恩病患者血清中,免疫稳态紊乱先于诊断出现,并可在非炎症克罗恩病黏膜中检出。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (aGMAbs) are detected in patients with ileal Crohn's disease (CD). Their induction and mode of action during or before disease are not well understood. We aimed to investigate the underlying mechanisms associated with aGMAb induction, from functional orientation to recognized epitopes, for their impact on intestinal immune homeostasis and use as a predictive biomarker for complicated CD. METHODS: We characterized using enzyme-linked immunosorbent assay naturally occurring aGMAbs in longitudinal serum samples from patients archived before the diagnosis of CD (n = 220) as well as from 400 healthy individuals (matched controls) as part of the US Defense Medical Surveillance System. We used biochemical, cellular, and transcriptional analysis to uncover a mechanism that governs the impaired immune balance in CD mucosa after diagnosis. RESULTS: Neutralizing aGMAbs were found to be specific for post-translational glycosylation on granulocyte macrophage-colony stimulating factor (GM-CSF), detectable years before diagnosis, and associated with complicated CD at presentation. Glycosylation of GM-CSF was altered in patients with CD, and aGMAb affected myeloid homeostasis and promoted group 1 innate lymphoid cells. Perturbations in immune homeostasis preceded the diagnosis in the serum of patients with CD presenting with aGMAb and were detectable in the noninflamed CD mucosa. CONCLUSIONS: Anti-GMAbs predict the diagnosis of complicated CD long before the diagnosis of disease, recognize uniquely glycosylated epitopes, and impair myeloid cell and innate lymphoid cell balance associated with altered intestinal immune homeostasis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Mortha A, Remark R, Del Valle DM, et al. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease. Gastroenterology. 2022. PMID: 35623454. doi:10.1053/j.gastro.2022.05.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。